First Time Loading...

Fluidigm Corp
NASDAQ:FLDM

Watchlist Manager
Fluidigm Corp Logo
Fluidigm Corp
NASDAQ:FLDM
Watchlist
Price: 3.71 USD -7.02% Market Closed
Updated: Mar 28, 2024

Intrinsic Value

FLDM price has not been updated for more than 9 months. This may indicate that the stock has been delisted.

Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. [ Read More ]

There is not enough data to reliably calculate the intrinsic value of FLDM.

Key Points:
FLDM Intrinsic Value
Base Case
Not Available
Base Case Scenario

Fundamental Analysis

How can I assist you today?

Provide an overview
of Fluidigm Corp's business.

What risks and challenges
does Fluidigm Corp face in the near future?

Summarize the latest earnings report
of Fluidigm Corp.

Provide P/E
for Fluidigm Corp and its competitors.

Financials

Balance Sheet Decomposition
Fluidigm Corp

Current Assets 72.1m
Cash & Short-Term Investments 28.5m
Receivables 18.3m
Other Current Assets 25.3m
Non-Current Assets 203.1m
PP&E 65.2m
Intangibles 29.2m
Other Non-Current Assets 108.8m
Current Liabilities 49.6m
Accounts Payable 10.6m
Accrued Liabilities 16.6m
Other Current Liabilities 22.3m
Non-Current Liabilities 131.1m
Long-Term Debt 64.2m
Other Non-Current Liabilities 66.8m
Efficiency

Earnings Waterfall
Fluidigm Corp

Revenue
130.6m USD
Cost of Revenue
-61.2m USD
Gross Profit
69.4m USD
Operating Expenses
-136.8m USD
Operating Income
-67.5m USD
Other Expenses
8.2m USD
Net Income
-59.2m USD

Free Cash Flow Analysis
Fluidigm Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

FLDM Profitability Score
Profitability Due Diligence

Fluidigm Corp's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

21/100
Profitability
Score

Fluidigm Corp's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

FLDM Solvency Score
Solvency Due Diligence

Fluidigm Corp's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
32/100
Solvency
Score

Fluidigm Corp's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

FLDM Price Targets Summary
Fluidigm Corp

There are no price targets for FLDM.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

FLDM Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

FLDM Price
Fluidigm Corp

1M 1M
-
6M 6M
-
1Y 1Y
-
3Y 3Y
-14%
5Y 5Y
-72%
10Y 10Y
-91%
Annual Price Range
3.71
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return 1.72%
Standard Deviation of Annual Returns 106.17%
Max Drawdown -91%
Shares Statistics
Market Capitalization 285.4m USD
Shares Outstanding 77 198 600
Percentage of Shares Shorted 8.46%

FLDM Return Decomposition
Main factors of price return

What is price return decomposition?

FLDM News

Other Videos

Company Profile

Fluidigm Corp Logo
Fluidigm Corp

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

285.4m USD

Dividend Yield

0%

Description

Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.

Contact

CALIFORNIA
South San Francisco
2 Tower Place, Suite 2000
+16502666000.0
https://www.fluidigm.com/

IPO

2011-02-10

Employees

615

Officers

Pres, CEO & Director
Mr. Stephen Christopher Linthwaite
Chief Financial Officer
Mr. Vikram Jog
Sr. VP of Global Operations
Mr. Bradley Allen Kreger
Sr. VP, Gen. Counsel & Corp. Sec.
Mr. Nicholas S. Khadder
Chief Commercial Officer
Mr. Colin McCracken
Co-Founder & Chairman of Advisory Board
Dr. Stephen R. Quake D.phil., Ph.D.
Show More
Chief Science Officer
Mr. Andrew Quong
Investor Relations
Mr. Peter DeNardo
Sr. Director of Corp. Communications
Mark Spearman
Chief HR Officer
Ms. Angela Peters
Show Less

See Also

Discover More